198 related articles for article (PubMed ID: 28646538)
1. A novel ATTR L32V mutation causes familial amyloid polyneuropathy in a Bolivian family.
Martínez-Ulloa PL; Vallejo M; Corral I; García-Barragán N; Alcazar A; Martínez-Alonso E; Martínez-Poles J; Pian H; Jiménez-Escrig A
J Peripher Nerv Syst; 2017 Sep; 22(3):208-212. PubMed ID: 28646538
[TBL] [Abstract][Full Text] [Related]
2. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
[TBL] [Abstract][Full Text] [Related]
3. A new transthyretin variant (Glu61Gly) associated with cardiomyopathy.
Rosenzweig M; Skinner M; Prokaeva T; Théberge R; Costello C; Drachman BM; Connors LH
Amyloid; 2007 Mar; 14(1):65-71. PubMed ID: 17453626
[TBL] [Abstract][Full Text] [Related]
4. Familial amyloid polyneuropathy in Korea: the first case report with a proven ATTR Lys35Asn gene.
Ryu JK; Baik HW; Bae JS; Hwang TJ; Paik SY; Yu HJ; Choi BO; Takei Y; Ikeda S
Amyloid; 2005 Mar; 12(1):62-4. PubMed ID: 16076613
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
[TBL] [Abstract][Full Text] [Related]
7. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
[TBL] [Abstract][Full Text] [Related]
8. A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
Jimenez-Zepeda VH; Bahlis NJ; Gilbertson J; Rendell N; Porcari R; Lachmann HJ; Gillmore JD; Hawkins PN; Rowczenio DM
Amyloid; 2015 Mar; 22(1):26-30. PubMed ID: 25430583
[TBL] [Abstract][Full Text] [Related]
9. Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).
Nakase T; Yamashita T; Matsuo Y; Nomura T; Sasada K; Masuda T; Misumi Y; Takamatsu K; Oda S; Furukawa Y; Obayashi K; Matsui H; Ando Y; Ueda M
Intern Med; 2019 Sep; 58(18):2695-2698. PubMed ID: 31178489
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case.
Kaplan B; Shinar Y; Avisar C; Livneh A
Clin Chem Lab Med; 2007; 45(5):625-8. PubMed ID: 17484624
[TBL] [Abstract][Full Text] [Related]
12. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
13. An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy.
Frigerio R; Fabrizi GM; Ferrarini M; Cavallaro T; Brighina L; Santoro P; Agostoni E; Cavaletti G; Rizzuto N; Ferrarese C
Amyloid; 2004 Jun; 11(2):121-4. PubMed ID: 15478468
[TBL] [Abstract][Full Text] [Related]
14. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
15. A novel variant mutation of transthyretin Ile73Val-related amyloidotic polyneuropathy in Taiwanese.
Liao MF; Chang HS
Acta Neurol Taiwan; 2013 Jun; 22(2):87-92. PubMed ID: 24030042
[TBL] [Abstract][Full Text] [Related]
16. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
[TBL] [Abstract][Full Text] [Related]
17. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
Liu T; Zhang B; Jin X; Wang W; Lee J; Li J; Yuan H; Cheng X
Eye (Lond); 2014 Jan; 28(1):26-33. PubMed ID: 24113303
[TBL] [Abstract][Full Text] [Related]
20. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
